Molina Healthcare (NYSE:MOH) was downgraded by equities research analysts at Wolfe Research from an “outperform” rating to a “market perform” rating in a research note issued on Thursday, January 3rd, The Fly reports.
Several other equities analysts also recently weighed in on the company. Zacks Investment Research upgraded Molina Healthcare from a “hold” rating to a “strong-buy” rating and set a $155.00 target price on the stock in a research report on Tuesday, October 23rd. Jefferies Financial Group upgraded Molina Healthcare from a “hold” rating to a “buy” rating and increased their target price for the stock from $152.00 to $169.00 in a research report on Tuesday, November 13th. ValuEngine downgraded Molina Healthcare from a “hold” rating to a “sell” rating in a research report on Friday, December 21st. Piper Jaffray Companies increased their target price on Molina Healthcare to $165.00 and gave the stock an “overweight” rating in a research report on Wednesday, September 26th. Finally, Morgan Stanley increased their target price on Molina Healthcare from $132.00 to $178.00 and gave the stock an “overweight” rating in a research report on Wednesday, September 5th. One equities research analyst has rated the stock with a sell rating, six have given a hold rating, seven have issued a buy rating and one has issued a strong buy rating to the company. The company has an average rating of “Buy” and an average price target of $140.92.
Shares of NYSE:MOH opened at $133.38 on Thursday. The company has a current ratio of 1.40, a quick ratio of 1.40 and a debt-to-equity ratio of 0.78. Molina Healthcare has a 52-week low of $71.07 and a 52-week high of $154.06. The firm has a market capitalization of $8.15 billion, a PE ratio of 238.18, a P/E/G ratio of 1.26 and a beta of 1.62.
Molina Healthcare (NYSE:MOH) last issued its quarterly earnings data on Wednesday, October 31st. The company reported $2.55 earnings per share (EPS) for the quarter, beating the Thomson Reuters’ consensus estimate of $1.65 by $0.90. Molina Healthcare had a return on equity of 30.50% and a net margin of 1.27%. The business had revenue of $4.70 billion for the quarter, compared to the consensus estimate of $4.72 billion. During the same period in the prior year, the business earned ($1.62) earnings per share. The business’s revenue was down 6.6% on a year-over-year basis. On average, equities analysts anticipate that Molina Healthcare will post 8.12 EPS for the current fiscal year.
In other Molina Healthcare news, Director Ronna Romney sold 200 shares of the firm’s stock in a transaction that occurred on Monday, December 3rd. The stock was sold at an average price of $141.23, for a total transaction of $28,246.00. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through the SEC website. Also, Director Steven J. Orlando sold 1,000 shares of the stock in a transaction that occurred on Wednesday, November 14th. The stock was sold at an average price of $135.86, for a total value of $135,860.00. The disclosure for this sale can be found here. In the last 90 days, insiders have sold 9,195 shares of company stock valued at $1,187,506. 0.65% of the stock is owned by insiders.
A number of large investors have recently added to or reduced their stakes in the business. Russell Investments Group Ltd. lifted its holdings in shares of Molina Healthcare by 62.8% in the 2nd quarter. Russell Investments Group Ltd. now owns 73,092 shares of the company’s stock worth $7,164,000 after purchasing an additional 28,192 shares during the last quarter. American Century Companies Inc. bought a new stake in shares of Molina Healthcare in the 2nd quarter worth approximately $2,571,000. CIBC Asset Management Inc bought a new stake in shares of Molina Healthcare in the 2nd quarter worth approximately $211,000. Legal & General Group Plc lifted its holdings in shares of Molina Healthcare by 14.0% in the 2nd quarter. Legal & General Group Plc now owns 77,419 shares of the company’s stock worth $7,582,000 after purchasing an additional 9,533 shares during the last quarter. Finally, FMR LLC lifted its holdings in shares of Molina Healthcare by 85.3% in the 2nd quarter. FMR LLC now owns 4,584,133 shares of the company’s stock worth $448,970,000 after purchasing an additional 2,110,308 shares during the last quarter.
Molina Healthcare Company Profile
Molina Healthcare, Inc provides Medicaid-related solutions to meet the health care needs of low-income families and individuals; and to assist state agencies in their administration of the Medicaid program in the United States. It operates through three segments: Health Plans, Molina Medicaid Solutions, and Other.
Further Reading: Determine Your Level of Risk Tolerance
Receive News & Ratings for Molina Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Molina Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.